| Financial Year |
March 31 2023 |
| Monetary Funds |
214,876,434.64 |
| Held-for-trading Financial Assets |
678,719,674.91 |
| Notes Receivable |
6,340,000.00 |
| Accounts Receivable |
197,358,112.76 |
| Advances to Suppliers |
5,792,041.62 |
| Other Receivables |
14,624,139.43 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
343,599,514.70 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
20,632,485.05 |
| Total Current Assets |
1,548,805,838.82 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
15,324,125.62 |
| Fixed Assetes |
159,142,202.87 |
| Under-construction Projects |
119,539,659.40 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
137,526,547.64 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,876,627.92 |
| Deferred Income Tax Assets |
19,616,968.36 |
| Other Non-Current Assets |
29,452,697.75 |
| Sub-Total of Non-Current Assets |
484,166,808.72 |
| Total Assets |
2,032,972,647.54 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
49,549,347.55 |
| Accounts Payable |
172,336,938.24 |
| Accounts Received In Advance |
19,504,803.07 |
| Employee Compensation Payable |
15,455,882.90 |
| Taxes Payable |
19,623,196.11 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
4,757,357.70 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
47,964,251.31 |
| Sub-Total of Current Liabilities |
762,614,435.50 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
20,155,845.60 |
| Deferred Income Tax Liabilities |
1,136,648.25 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
54,850,558.74 |
| Total Liabilities |
817,464,994.24 |
| Paid-In Capital(Or Share Stock) |
336,687,900.00 |
| Capital Surplus |
415,305,301.27 |
| Surplus Reserve |
101,879,107.42 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
344,152,176.84 |
| Minority Stockholder's Interest |
-254,946.21 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,215,762,599.51 |
| Owner's Equity（Stockholder's Equity） |
1,215,507,653.30 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,032,972,647.54 |
